Sign up to save your podcasts
Or
Share Residual tumor volume and survival after CCNU/TMZ in GBM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
More shows like Neuro-Oncology: The Podcast
View all
Global News Podcast
7,688 Listeners
Science Weekly
415 Listeners
Freakonomics Radio
32,040 Listeners
The Daily
110,847 Listeners
Up First from NPR
55,848 Listeners
OncLive® On Air
21 Listeners
Lung Cancer Considered
26 Listeners
Neurosurgery Podcast
111 Listeners
The Rest Is History
12,474 Listeners
The Ezra Klein Show
15,321 Listeners
The Weekly Show with Jon Stewart
10,249 Listeners
Pop Culture Parenting
68 Listeners
Glioblastoma aka GBM
25 Listeners
Oncology for the Inquisitive Mind
4 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
38 Listeners